FINWIRES · TerminalLIVE
FINWIRES

Stocks Decline Pre-Bell Amid Uncertainty Over US-Iran Truce; Key Inflation Report on Deck

-- US equity markets were trending lower before the opening bell Thursday as investors assess uncertainty over the recent two-week ceasefire deal between the US and Iran, and await a key inflation report.

The S&P 500 and the Dow Jones Industrial Average declined 0.3% each in premarket activity, while the Nasdaq was off 0.2%. The indexes finished Wednesday's trading in the green, recording their highest close in at least four weeks.

In a Wednesday post on X, Iran's parliamentary speaker, Mohammad Bagher Ghalibaf, said the US violated three clauses of Tehran's 10-point ceasefire proposal. The violations include Israel's attacks on Lebanon, the entry of a drone into Iranian airspace and the denial of Tehran's right to enrich uranium, according to Ghalibaf.

"The deep historical distrust we hold toward the (US) stems from its repeated violations of all forms of commitments - a pattern that has regrettably been repeated once again," Ghalibaf said. "In such situation, a bilateral ceasefire or negotiations is unreasonable."

In a late Wednesday post on Truth Social, President Donald Trump said US ships, aircraft and military personnel will "remain in and around Iran" until the "real agreement reached is fully complied with."

"It was agreed, a long time ago, and despite all of the fake rhetoric to the contrary - no nuclear weapons and, the Strait of Hormuz will be open and safe," according to Trump.

On Tuesday, Trump announced that he agreed to suspend attacks on Iran for a period of two weeks, subject to Tehran agreeing to the complete and safe opening of the strait, the world's most important chokepoint for crude flows. Iranian Foreign Minister Seyed Abbas Araghchi had said in a statement that the country will allow "safe passage" through the strait during the two-week ceasefire through coordination with its armed forces and "with due consideration of technical limitations."

Delegations from both countries are scheduled to meet in Islamabad, Pakistan on Friday to negotiate a "conclusive agreement to settle all disputes," Pakistani Prime Minister Shehbaz Sharif said Tuesday.

West Texas Intermediate crude oil rose 3.5% to $97.70 a barrel before the open, while Brent increased 3.3% to $97.87.

"The headlines may calm down first, but the real reset depends on what happens in the days ahead," Charu Chanana, chief investment strategist at Saxo Bank, said in a report Wednesday.

The delayed personal income and outlays report for February is scheduled to be released at 8:30 am ET. The report includes the personal consumption expenditure core price index, the Federal Reserve's preferred inflation metric.

Minutes from the Federal Reserve's March meeting showed Wednesday that participants emphasized the need for the central bank to be "nimble" in adjusting monetary policy amid heightened macro risks. Most policymakers were concerned that a prolonged war could soften labor market conditions, possibly warranting policy easing, according to the minutes. However, persistent inflation amid higher oil prices could call for rate increases.

Markets widely expect the Fed to keep its benchmark lending rate steady at its next policy meeting later in April, according to the CME FedWatch tool.

Treasury yields were down in premarket action, with the two-year rate retreating 0.5 basis points to 3.79% and the 10-year rate off 0.4 basis points to 4.29%.

Thursday's economic calendar also has the delayed final estimate report for the fourth-quarter gross domestic product at 8:30 am, as well as the weekly jobless claims report.

Shares of Constellation Brands (STZ) declined 0.9% pre-bell after the beer and wine company issued a full-year earnings outlook below Wall Street's estimates.

Neogen (NEOG), BlackBerry (BB) and Simply Good Foods (SMPL) report their latest financial results before the bell, among others. WD-40 (WDFC) posts its earnings after the markets close.

Gold sipped 0.5% to $4,752 per troy ounce, while bitcoin nudged up 0.2% to $71,399.

相关文章

Australia

再生元公司称,FDA已加速批准其治疗遗传性听力损失的疗法

再生元公司(Regeneron,股票代码:REGN)周四宣布,美国食品药品监督管理局(FDA)已加速批准其治疗OTOF基因相关听力损失的药物Otarmeni用于治疗儿童和成人患者。 根据一份声明,FDA的批准基于正在进行的Chord试验。该试验显示,20名受试者中有16名在纯音测听评估中听力有所改善,其中14名表现出听觉脑干反应。 再生元公司表示,Otarmeni的持续批准可能取决于Chord试验验证性部分中临床获益的验证和描述。 该公司表示,将为美国符合临床条件的患者免费提供Otarmeni。 该公司股价周四上涨2%。Price: $761.47, Change: $+14.89, Percent Change: +1.99%

$REGN
Sectors

行业动态:医疗保健

周四下午,医疗保健类股下跌,纽约证券交易所医疗保健指数下跌0.5%,道富医疗保健精选行业SPDR ETF (XLV)下跌0.7%。 iShares生物技术ETF (IBB)下跌1.9%。 公司新闻方面,赛默飞世尔科技(TMO)周四上调了全年业绩预期,原因是其第一季度业绩强于预期,尽管内生增长低于分析师预期。该公司股价下跌10.9%。

$TMO
Research

美国银行称,德州仪器将受益于工业复苏和数据中心需求增长。

美国银行周四发布的一份报告指出,德州仪器 (TXN) 有望受益于工业复苏,尤其是在航空航天/国防、数据中心需求以及其美国本土制造业务带来的收益增长。 该券商还表示,随着德州仪器逐步摆脱大规模资本支出周期,其自由现金流有望更加强劲。报告还指出,德州仪器能够利用过去三年在美国晶圆厂的巨额资本支出,在“资源受限”的芯片市场中抢占市场份额。 美国银行还表示,看好德州仪器在直流电源领域的定位,该公司“在机架级产品中占据主导地位,并且随着架构向更高电压/更高功率密度系统发展,其专用插座业务也呈现增长势头”。 然而,美国银行指出,持续的地缘政治动荡仍然是整个行业面临的风险,但补充说,德州仪器历来具有相对更强的防御性。 美国银行将该股评级从“中性”上调至“买入”,并将目标价从 235 美元上调至 320 美元。Price: $283.62, Change: $+47.31, Percent Change: +20.02%

$TXN